Spectralis is a multimodal retinal imaging platform designed to support the diagnosis and monitoring of macular disease.
Confocal scanning laser ophthalmoscopy (cSLO), combined with high-resolution spectral-domain optical coherence tomography (OCT), enables simultaneous fundus and cross-sectional imaging with precise point-to-point correlation, helping clinicians visualise retinal microstructure in detail.
The Shift technology allows OCT scan speeds to be adapted to clinical needs: high-sensitivity 20 kHz scanning improves image quality in difficult-to-image eyes with media opacities, while 125 kHz scanning is optimised for OCT angiography to evaluate macular microvasculature. BluePeak fundus autofluorescence combined with OCT is widely used to assess and monitor geographic atrophy progression. TruTrack active eye tracking, ART image averaging, and AutoRescan support high-quality images and precise follow up for monitoring macular disease over time.
Contact: Heidelberg Engineering (AUS) 1300 434 357 or sales-au@heidelbergengineering.com
